PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 3, 2026BMC Pulmonary Medicine0 citationsOpen Access

Flow rate dependence of salbutamol dose with various valved holding chambers in vitro

VVVille VartiainenLLLauri LehtimäkiMCMikael Csonka

Key Points

  • This study assesses how different inhalation flow rates impact the delivery of salbutamol using various valved holding chambers.
  • Comparison of two reusable (Vortex and OptiChamber Diamond) and two disposable (DispoZABLE and LiteAire) holding chambers.
  • Connected HCs to an anatomical throat model and breathing simulator to measure deposited drug content using high performance liquid chromatography.
  • Inhalation patterns were tested at peak inspiratory flow rates of 15, 30, 60, and 80 l/min.
  • All holding chambers significantly reduced throat deposition by at least 80%.
  • Higher peak inspiratory flow rates led to increased throat deposition.
  • Flow dependency observed in fine particle dose varied between different holding chambers.

Abstract

BACKGROUND: Inhalation is the primary administration route for managing airway diseases like asthma and COPD. Presently, treatment protocols for management of acute obstruction in emergency care involve using either pressurized metered dose inhalers (pMDI), often with holding chambers (HC), or nebulizers. The aim of this work was to assess the impact of different inhalation patterns and specifically peak inspiratory flow rate (PIF) on drug delivery, as well as to provide a head-to-head comparison between different (HC) in combination with a salbutamol pMDI. METHODS: For the comparison we chose two reusable (Vortex and OptiChamber Diamond) and two disposable (DispoZABLE and LiteAire) HCs. The HCs were connected to an anatomical throat model, Next Generation Impactor, and breathing simulator and the deposited drug content was measured with high performance liquid chromatography. In the used inhalation patterns the PIFs were 15 l/min, 30 l/min, 60 l/min, and 80 l/min. RESULTS: All HCs decreased throat deposition by at least 80%, but throat deposition increased with higher PIF. There was some flow-dependency also in fine particle dose (FPD) but the direction of the dependency varied between the HCs. CONCLUSIONS: The performance of disposable devices in terms of flow dependency and throat deposition was similar to reusable ones.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Vartiainen et al. (2026) studied this question.

synapsesocial.com/papers/6a4750f45c29257aa2578613https://doi.org/10.1186/s12890-026-04456-z
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In Vitro Performance of Valved Holding Chambers in Paediatric Asthma Controller Therapy2026
  2. 2<i>In vitro</i> performance of an improved collapsible holding chamber (CHC) for the delivery of bronchodilators to patients receiving mechanical ventilation2011
  3. 3Inhaled salbutamol delivery in small children with disposable and reusable spacers: an in vitro study2025 · 4 citations
  4. 4Inhaled corticosteroid delivery is markedly affected by breathing pattern and valved holding chamber model2024 · 8 citations
  5. 5Enhancing aerosol delivery in asthma and COPD: a comparison of MDI, valved holding chamber, and DPI systems using functional respiratory imaging (FRI).2026 · 2 citations